{"id":"W2526148797","doi":"10.1200/jco.2014.32.15_suppl.7501","title":"A randomized, double-blind phase 3 trial of adjuvant erlotinib (E) versus placebo (P) following complete tumor resection with or without adjuvant chemotherapy in patients (pts) with stage IB-IIIA EGFR positive (IHC/FISH) non-small cell lung cancer (NSCLC): RADIANT results.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Rash; Erlotinib; Clinical endpoint; Chemotherapy; Oncology; Surgery; Gastroenterology; Randomized controlled trial; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002313339,0.002336126,0.00310294,0.0005721663,0.0005795827,0.001119548,0.0014156,0.002228189,0.008167543],"category_scores_gemma":[0.002360197,0.0009639895,0.001634081,0.0004980227,0.001710317,0.001540287,0.0005171623,0.002917536,0.001628608],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008772818,"about_ca_system_score_gemma":0.001566852,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000888963,"about_ca_topic_score_gemma":0.002336097,"domain_scores_codex":[0.9991837,0.0004751633,0.00004015449,0.0001387722,0.00004955477,0.0001126373],"domain_scores_gemma":[0.9988005,0.0003624776,0.0002764172,0.0001169861,0.00007308383,0.000370439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9877012,0.00528744,0.0001463787,0.0002022023,0.0002437525,0.00001560447,0.0000240954,0.0001853468,0.001197442,0.0000586587,0.0004024864,0.004535401],"study_design_scores_gemma":[0.9620801,0.03685459,0.000320523,0.000009783937,0.0001083406,0.0000106578,0.000008017267,0.0002119079,0.0001427114,0.00008685404,0.0001598542,0.000006691481],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9794288,0.002256643,0.001175892,0.000780831,0.0009468956,0.01080739,0.001869591,0.0002336638,0.002500255],"genre_scores_gemma":[0.9732031,0.001456796,0.002386156,0.001396149,0.0005461941,0.01471498,0.001341454,0.0000419775,0.004913175],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008167543,"threshold_uncertainty_score":0.02732313,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07699324678474728,"score_gpt":0.457988531164614,"score_spread":0.3809952843798667,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}